Overview

Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
This prospective, randomized, double-blind, placebo-controlled study to determine whether intrathecal dexmedetomidine, administered along with hyperbaric bupivacaine for covering Cesarean delivery decreases the incidence of shivering associated with spinal anesthesia
Phase:
PHASE3
Details
Lead Sponsor:
Al-Azhar University
Treatments:
Dexmedetomidine
Population Groups
Sodium Chloride